Shares of Avidity Biosciences RNA have soared 36% in the past month, all thanks to a report issued by the Financial Times (FT ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Novartis AG said an experimental medicine helped patients with an autoimmune disease in late-stage studies, offering a boost for the Swiss drugmaker’s efforts in the field.

Citi wrote that concerns regarding Entresto going generic in the US may start fading away as the company continues to supply ...

And if you're looking for top dividend-paying companies to put your money in right now, let's consider two excellent ...

Novartis has made a takeover approach for rare disease-focused biotech Avidity Biosciences, as Big Pharma continues to hunt for deals to offset looming patent cliffs, according to people familiar with ...

A federal judge rejected Novartis’ request for a preliminary injunction to stop MSN Pharmaceuticals from selling a generic version of the blockbuster heart medication Entresto. In a decision, U.S.

The Swiss pharmaceutical company is bracing for the patent expiration--and the arrival of generic competitors--for its heart drug Entresto, the group's best-selling medicine, at a time investors ...

" data-display-label="0" data-show-count="1" data-bookmark-label="Save" data-bookmarked-label="Saved" data-loggedin="0" data-type="post" data-object_id="338625" class="cbxwpbkmarktrig ...